X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ORVOSI HETILAP

期刊標題檢索 ORVOSI HETILAP 最新評論: Hello, does this magazine have a cover letter template? (2023-06-10)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ORVOSI HETILAP]您好,您是該頁面的第 9116 位訪客。

期刊簡介
期刊名稱ORVOSI HETILAP ORVOSI HETILAP
LetPub Score
5.0
50 ratings
Rate

Reputation
5.8

Influence
3.6

Speed
8.8

期刊簡稱ORVOSI HETILAP
ISSN0030-6002
E-ISSN1788-6120
h-index18
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.200.2140.343
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: General Medicine
Q3320 / 636

自引率 (2023-2024)62.50%自引率趨勢
掲載範囲
The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history.

Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary.

The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
官方網站http://www.akademiai.com/loi/650
在線稿件提交
開放訪問No
出版商Akademiai Kiado
主題領域MEDICINE, GENERAL & INTERNAL
出版國/地區HUNGARY
發行頻率
創刊年0
每年文章數235每年文章數趨勢
黃金OA百分比83.17%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, GENERAL & INTERNALSCIEQ3190/325
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0030-6002%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【ORVOSI HETILAP】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640704
    BIOMATERIALS569630
    BIOMEDICINE & PHARMACOTHERAPY498327
    Frontiers in Pharmacology486598
    Journal of Materials Chemistry B476055
    JOURNAL OF ETHNOPHARMACOLOGY475801
    Frontiers in Immunology457847
    COLLOIDS AND SURFACES B-BIOINTERFACES419210
    COMPUTERS IN BIOLOGY AND MEDICINE416252
    Frontiers in Oncology413355
  •  

    ORVOSI HETILAP ORVOSI HETILAP
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [ORVOSI HETILAP] 的評論撰寫評論
作者: Dorothy Wycliffe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-10 23:46:27 評論於
Hello, does this magazine have a cover letter template?
(0) 讚! | Dorothy Wycliffe

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:39:56 評論於
There is usually no word count limit, but it should make up a certain proportion
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:13:18 評論於
The emphasis should be placed on including as much preliminary research as possible, with no limit on the number of papers
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:30:29 評論於
How many references are generally cited in an introduction?
(0) 讚! | Darlene Pepys

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 15:26:22 評論於
Introduction usually consists of how many words?
(0) 讚! | 龙鳞孝礼

作者: 这就是命


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2018-08-17 16:35:36 評論於
I only saw the self-citation rate after my paper was rejected. Maybe they rejected my paper because I didn't cite articles from this journal.

(0) 讚! | 这就是命

作者: 极乐艺霖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-17 09:40:33 評論於
Review speed: 3.0 | Submission hit rate: 75.0 Experience sharing: After being rejected, I noticed the self-citation rate of this journal. It's probably because I didn't cite any articles from their journal that I was rejected
(0) 讚! | 极乐艺霖

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [ORVOSI HETILAP] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*